Patients in the semaglutide treatment arm of STEP 1 were more likely to be exposed to the medication at the full dose of 2.4 mg than those in SELECT
Its your mitochondria screaming for a level-up
Because GHK-Cu arrives as lyophilized powder reconstituted to a researcher-chosen concentration, the same target dose corresponds to different syringe volumes depending on the reconstitution choice
Potential side effects include: Injection site reactions, including redness, swelling, bruising, pain, or irritation Mild fluid retention (edema) Joint or muscle discomfort Headache, dizziness, or flushing Changes in glucose regulation, particularly in individuals with diabetes or prediabetes Itching, restlessness, drowsiness, nausea, or difficulty swallowing (3) Importantly, the occurrence of potential side effects does not predict an individual's overall response to therapy
Shepherd G, Velez LI